Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Rossignol Rodrigue"

From Bioblast
Line 3: Line 3:
|firstname=Rodrigue
|firstname=Rodrigue
|title=Dr.
|title=Dr.
|institution=[[File:RossignolR.jpg|150px|right|Rodrigue Rossignol]]
|institution=[[File:Rossignol.jpg|150px|right|Rodrigue Rossignol]]


INSERM CR1
INSERM CR1

Revision as of 15:14, 14 August 2013

Name Rossignol Rodrigue, Dr.
Institution
Rodrigue Rossignol

INSERM CR1

Université Victor Segalen-Bordeaux 2

EA 4576 Maladies Rares: Génétique et Métabolisme

Ecole des sages femmes de Bordeaux

Centre Hospitalier Universitaire

Groupe Pellegrin Place Amélie Raba-Léon

Address , 33076
City Bordeaux cedex
State/Province
Country France
Email [email protected]
Weblink
O2k-Network Lab FR Bordeaux Rossignol R


Labels:



Publications

 PublishedReference
Amoedo 2021 J Clin Invest2021Amoedo ND, Sarlak S, Obre E, Esteves P, Bégueret H, Kieffer Y, Rousseau B, Dupis A, Izotte J, Bellance N, Dard L, Redonnet-Vernhet I, Punzi G, Rodrigues MF, Dumon E, Mafhouf W, Guyonnet-Dupérat V, Gales L, Palama T, Bellvert F, Dugot-Senan N, Claverol S, Baste JM, Lacombe D, Rezvani HR, Pierri CL, Mechta-Grigoriou F, Thumerel M, Rossignol R (2021) Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest 131:e133081.
Bastos Sant'Anna Silva 2021 Cancers (Basel)2021Bastos Sant'Anna Silva AC, Perez Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. https://doi.org/10.3390/cancers13071727
BEC 2020.1 doi10.26124bec2020-0001.v12020Gnaiger E et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1
Esteves 2019 Oncogene2019Esteves P, Dard L, Brillac A, Hubert C, Sarlak S, Rousseau B, Dumon E, Izotte J, Bonneu M, Lacombe D, Dupuy JW, Amoedo N, Rossignol R (2019) Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene 39:617-36.
Szelechowski 2018 Sci Rep2018Szelechowski M, Amoedo N, Obre E, Léger C, Allard L, Bonneu M, Claverol S, Lacombe D, Oliet S, Chevallier S, Le Masson G, Rossignol R (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep 8:3953.
Jose 2018 Redox Biol2018Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D, Rezvani HR, Pourquier P, Nouette-Gaulain K, Rossignol R (2018) Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18:33-42.
Rodrigues 2016 Biochem J2015Rodrigues MF, Obre E, Melo FH, Santos-Jr GC, Galina A, Jasiulionis MG, Rossignol R, Rumjanek FD, Amoedo ND (2016) Enhanced OXPHOS, glutaminolysis and beta-oxidation constitute the metastatic phenotype of melanoma cells. https://doi.org/10.1042/BJ20150645
Willems 2015 Cell Metab2015Willems PH, Rossignol R, Dieteren CE, Murphy MP, Koopman WJH (2015) Redox homeostasis and mitochondrial dynamics. Cell Metab 22:207-18.
Melser 2013 Cell Metab2013Melser S, Chatelain EH, Lavie J, Mahfouf W, Jose C, Obre E, Goorden S, Priault M, Elgersma Y, Rezvani HR, Rossignol R, Bénard G (2013) Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab 17:719-30.
Benard 2011 Springer2011Benard G, Bellance N, Jose C, Rossignol R (2011) Relationships between mitochondrial dynamics and bioenergetics. In: Lu Bingwei (ed) Mitochondrial dynamics and neurodegeneration. Springer ISBN 978-94-007-1290-4:47-68.
Smolkova 2010 J Bioenerg Biomembr2010Smolková K, Bellance N, Scandurra F, Génot E, Gnaiger E, Plecitá-Hlavatá L, Ježek P, Rossignol R (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. https://doi.org/10.1007/s10863-009-9267-x
Bellance 2009 Front Biosci (Landmark Ed)2009Bellance N, Lestienne P, Rossignol R (2009) Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. Front Biosci (Landmark Ed) 14:4015-34. doi: 10.2741/3509
Bellance 2009 Int J Biochem Cell Biol2009Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566-77.
Nouette-Gaulain 2009 Anesthesiology2009Nouette-Gaulain K, Bellance N, Prévost B, Passerieux E, Pertuiset C, Galbes O, Smolkova K, Masson F, Miraux S, Delage JP, Letellier T, Rossignol R, Capdevila X, Sztark F (2009) Erythropoietin protects against local anesthetic myotoxicity during continuous regional analgesia. Anesthesiology 110:648-59.
Benard 2008 Int J Biochem Cell Biol2008Benard G, Faustin B, Galinier A, Rocher C, Bellance N, Smolkova K, Casteilla L, Rossignol R, Letellier T (2008) Functional dynamic compartmentalization of respiratory chain intermediate substrates: implications for the control of energy production and mitochondrial diseases. Int J Biochem Cell Biol 40:1543-54.
Benard 2007 J Cell Sci2007Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, Rossignol R (2007) Mitochondrial bioenergetics and structural network organization. J Cell Sci 120:838-48.
Rossignol 2003 Biochem J2003Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T (2003) Mitochondrial threshold effects. Biochem J 370:751-62.

Abstracts

 PublishedReference
Amoedo 2015 Abstract MiP20152015The energy requirement of metastatic cells.
Rodrigues 2014 Abstract MiP20142014Bioenergetics’ traits of tongue cancer metastatic cells.
Koopman 2014 Abstract MiP20142014Redox regulation of mitochondrial dynamics and function.